Clinical trial
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High…
NCT00004074 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00004074 |
|---|---|
| Title | Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
| Official title | A Phase I Trial of Herceptin and Interleukin-12 |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases, Carcinoma of the Appendix, Distal Urethral Cancer, Fallopian Tube Cancer, Gastrinoma, Glucagonoma, Inflammatory Breast Cancer, Insulinoma and 117 more |
| Intervention type | Biological |
| Interventions | recombinant interleukin-12, ABI-007/carboplatin/trastuzumab |
| Enrollment | 15 |
| Start date | Aug 1, 1999 |
| Primary completion | Feb 1, 2009 |
| First posted | Oct 29, 2003 |
| Last update posted | Feb 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: